Aclaris Therapeutics Inc (ACRS)

Where is the price of $ACRS heading?

Stock Price

About the Company

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.

CEO

Neal Walker

Exchange

NASDAQ

Website

www.aclaristx.com

$10M

Total Revenue

59

Employees

$1B

Market Capitalization

-11.83

Price/Earning ratio

Company News

Aclaris Therapeutics Inc

2d ago, source: Reuters

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing drug candidates for immuno-inflammatory diseases. The Company is focused on leveraging its ...

Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations

6d ago, source: Yahoo Finance

WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno ...

Teachers Retirement System of The State of Kentucky Acquires 4,508 Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS)

11d ago, source: Defense World

Teachers Retirement System of The State of Kentucky boosted its holdings in shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS ...

Aclaris Therapeutics Inc (ACRS)

4d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations

7d ago, source: MarketWatch

The MarketWatch News Department was not involved in the creation of this content. WAYNE, Pa., Sep 27, 2022 (GLOBE NEWSWIRE via COMTEX) -- WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Aclaris ...

Aclaris Therapeutics Inc

18d ago, source: U.S. News & World Report

Here are the highest-rated stocks from Warren Buffett's portfolio, according to analysts.

Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations

7d ago, source: Yahoo Finance

WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory ...

My Portfolio